New Influenza D Test Developed for Field Monitoring
Researchers created a rapid diagnostic tool to help track the virus, which is prevalent in livestock and cattle-exposed humans.
Updated on Sept. 21, 2026 in Diseases — General
Live Poll
Do you feel confident in the national response to emerging zoonotic disease threats?
Scientists have developed a new, portable diagnostic assay designed to detect influenza D virus (IDV) in under an hour. This field-ready test provides an alternative to laboratory-based PCR, supporting improved monitoring of the virus in both animal and human populations.
Why it matters
While no active human influenza D infections have been confirmed, the virus is widespread in livestock, and antibody prevalence in cattle-exposed human cohorts reaches 97%. This new testing capability is essential for tracking potential spillover and monitoring emerging influenza threats.
The new RT-LAMP assay demonstrated a specificity of 99.2% and a sensitivity of 95.6% for cycle quantification under 30. Researchers developed this diagnostic to detect viral RNA in the field, providing a faster, more accessible alternative to standard quantitative reverse transcription PCR.
The details
The test utilizes reverse transcription loop-mediated isothermal amplification (RT-LAMP) to detect viral RNA at a constant temperature. This method simplifies the diagnostic process by removing the need for the complex thermal cycling required by traditional PCR. By allowing for rapid testing outside of centralized laboratories, this approach addresses the logistical challenges of monitoring influenza D across agricultural and research settings.
Timeline
2005: Seroprevalence of influenza D virus in the Italian general population was 5%.
2011: Influenza D virus was first discovered in pigs in Oklahoma.
2014: Seroprevalence of influenza D virus in the Italian general population reached 46%.
Health Landscape
This development expands the global diagnostic toolkit for the influenza family, bringing influenza D into the fold of monitored emerging threats. It represents a shift toward more accessible, field-ready diagnostics that can supplement the standard laboratory-based influenza surveillance networks.
This technology is currently designed for environmental and agricultural monitoring rather than routine clinical care. If you have concerns about zoonotic disease exposure through your occupation or hobbies, discuss these risks and appropriate protective measures with a medical provider.
The takeaway
Influenza D is highly prevalent in livestock and shows significant seroprevalence in humans who work with cattle, yet it remains distinct from the seasonal flu viruses that currently cause human illness. Track emerging research on zoonotic influenza and consult a physician if you work closely with livestock and develop respiratory symptoms.
Further reading
For broader context on emerging infectious threats and diagnostic monitoring, visit Diseases — General.
Source note: This article includes information reported by Cdc.
Live Poll
Do you feel confident in the national response to emerging zoonotic disease threats?
